Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001133416-23-000016
Filing Date
2023-01-30
Accepted
2023-01-30 16:38:36
Documents
1
Period of Report
2023-01-26

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3785
  Complete submission text file 0001133416-23-000016.txt   5243
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 FIFTH STREET NW STE. 313 ATLANTA GA 30308
Business Address
CALLICUTT JACK W (Reporting) CIK: 0001266773 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 23568373